Search Within

Matthew David Hellmann

  1. "Body Imaging Service"
Formats
  1. Journal Article (40)
  2. Meeting Abstract (23)
Groups
  1. Body Imaging Service (63)
  2. Department of Medicine (63)
  3. Radiology, Department of (63)
  4. Solid Tumor Oncology Division (63)
  5. Thoracic Oncology (63)
  6. Weinberg Fellows (38)

More Groups

People
  1. Andrew Plodkowski (47)
  2. Hira Rizvi (47)
  3. Kathryn Arbour (25)
  4. Mark Kris (25)
  5. Gregory Riely (20)
  6. Charles Rudin (19)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (10)
  4. 2021 (9)
  5. 2020 (11)
  6. 2019 (10)

More Years

Publications
  1. Journal of Clinical Oncology (18)
  2. Journal of Thoracic Oncology (9)
  3. Annals of Oncology (8)
  4. Clinical Cancer Research (5)
  5. Cancer Discovery (3)
  6. Cancer Cell (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. Elsevier Inc. (11)
  3. American Association for Cancer Research (10)
  4. Oxford University Press (9)
  5. Cell Press (3)
  6. Nature Publishing Group (3)

More Publishers

Results (63)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer
    Journal Article

    Boehm, K. M.; Aherne, E. A.; Ellenson, L.; Nikolovski, I.; Alghamdi, M.; Vázquez-García, I.; Zamarin, D.; Roche, K. L.; Liu, Y.; Patel, D.; more...
    Nature Cancer (2022)

    Fulltext@MSK | Save
  • Semisupervised training of a brain MRI tumor detection model using mined annotations
    Journal Article

    Swinburne, N. C.; Yadav, V.; Kim, J.; Choi, Y. R.; Gutman, D. C.; Yang, J. T.; Moss, N.; Stone, J.; Tisnado, J.; Hatzoglou, V.; more...
    Radiology (2022)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Diminished efficacy of programmed death-(ligand)1 inhibition in STK11- and KEAP1-mutant lung adenocarcinoma Is affected by KRAS mutation status
    Journal Article

    Ricciuti, B.; Arbour, K. C.; Lin, J. J.; Vajdi, A.; Vokes, N.; Hong, L.; Zhang, J.; Tolstorukov, M. Y.; Li, Y. Y.; Spurr, L. F.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Association of a very high tumor mutational load with increased CD8+ and PD-1+ T-cell infiltration and improved clinical outcomes to PD-(L)1 blockade across different PD-L1 expression levels in non-small cell lung cancer
    Meeting Abstract

    Ricciuti, B.; Arbour, K. C.; Alessi, J. V. M.; Mahadevan, N.; Lindsay, J.; Sinha, R.; Vokes, N. I.; Recondo, G.; Lamberti, G.; Rizvi, H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Determination of clinical benefit among patients with radiological stable disease to immune checkpoint inhibitors
    Meeting Abstract

    Luo, J.; Wu, S.; Rizvi, H.; Zhang, Q.; Egger, J. V.; Osorio, J. C.; Schoenfeld, A. J.; Plodkowski, A. J.; Ginsberg, M. S.; Gupta, A. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Intra- and inter-reader agreement of iRECIST and RECIST 1.1 criteria for the assessment of tumor response in patients receiving checkpoint inhibitor immunotherapy for lung cancer
    Journal Article

    Castellanos, S. H.; Pagano, A.; Plodkowski, A. J.; Girshman, J.; Hellmann, M. D.; Rizvi, H.; Flynn, J.; Zheng, J.; Capanu, M.; Halpenny, D. F.; more...
    Lung Cancer (2021)

    Fulltext@MSK | Save
  • Immunotherapy-mediated thyroid dysfunction: Genetic risk and impact on outcomes with PD-1 blockade in non-small cell lung cancer
    Journal Article

    Luo, J.; Martucci, V. L.; Quandt, Z.; Groha, S.; Murray, M. H.; Lovly, C. M.; Rizvi, H.; Egger, J. V.; Plodkowski, A. J.; Abu-Akeel, M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • A very high tumor mutational burden (TMB) is associated with improved efficacy of PD-(L)1 inhibition across different PD-L1 expression subgroups and a distinct immunophenotype in NSCLC
    Meeting Abstract

    Ricciuti, B.; Arbour, K. C.; Mahadevan, N. R.; Alessi, J. V.; Lindsay, J.; Umeton, R.; Sinha, R.; Hoojghan, A.; Vokes, N.; Recondo, G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics
    Journal Article

    Mezquita, L.; Preeshagul, I.; Auclin, E.; Saravia, D.; Hendriks, L.; Rizvi, H.; Park, W.; Nadal, E.; Martin-Romano, P.; Ruffinelli, J. C.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save